sanofi (SAN:Euronext Paris)
Gary J. Nabel M.D., Ph.D.
Chairman of the Strategic Development & Scientific Advisory Council, Chief Scientific Officer and Senior Vice President, Sanofi
|Age||Total Calculated Compensation||This person is connected to 17 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. Gary J. Nabel, M.D., Ph.D. has been the Chief Scientific Officer at Sanofi since November 2012 and has been its Senior Vice President since December 2012. Dr. Nabel served as Deputy to the President for Global Research & Development at Sanofi since November 2012. Dr. Nabel was Director of the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases at National Institutes of Health from 1999 to November 2012. Dr. Nabel served as Chairman ...
54, Rue La BoétiePhone: 33 1 53 77 40 00
Paris, Ile-de-France 75008
Board Members Memberships*
Bachelor's Degree 1975
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Kenneth C. Frazier||Chairman and Chief Executive Officer|
Merck & Co. Inc.
|$1.5M||Compensation as of Fiscal Year 2013.|